Thrive Capital Management, LLC

Q2 2022 13F Combination Report, Restatement, Stock Holdings

Signature - Title
Ashwin Budhiraja - Chief Financial Officer
Location
New York, NY
Holdings as of
June 30, 2022
Value $
$342M
Num holdings
8
Date filed
11/18/2022, 05:14 PM
Description
A portion of the US holdings for this investor are reported in this report and a portion are reported by other reporting manager(s). The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q1 2022 - Nov 18, 2022
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2022 Q2 - Restatement compared to 2022 Q1 - Restatement by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Ashwin Budhiraja Chief Financial Officer New York, New York 11/18/2022

This Amendment is being filed solely for the purpose of removing from the Form 13F Information Table certain shares of Class A Common Stock of Oscar Health, Inc. ("Class A Common") inadvertently included in the Form 13F filed by the Reporting Person for the quarter ended June 30, 2022. As of June 30, 2022, the Reporting Person or its affiliates exercised investment discretion over 32,859,064 shares of Class B Common Stock of Oscar Health, Inc. ("Class B Common"). While shares of Class A Common are Section 13(f) securities as defined in Rule 13f-1(c) under the Securities and Exchange Act of 1934, shares of Class B Common are not Section 13(f) securities and thus not reportable. For the avoidance of doubt, this Amendment is to correct a clerical error only, and there were no sales by the Reporting Person of shares of Class A Common or Class B Common during the quarter ended June 30, 2022.